If it can't reach the system of record, it didn't happen

A deal that has survived clinical review, security review and pricing can still die in the last mile, and it usually dies the same way.

The product produces something genuinely useful — a risk score, a suspected condition, a care gap, a documented reason a patient should be seen sooner. Then someone in the room asks where it goes, and the honest answer is a dashboard.

A dashboard is not the system of record. And in healthcare, work that never reaches the system of record has three problems at once.

One: it cannot be billed

Reimbursement follows documentation in the chart, coded correctly, signed by the right person on the right date. An insight sitting in a separate portal is not documentation. Whatever value it created is real clinically and invisible financially, which means it has to be justified out of a different budget than the one that would have funded it easily.

Two: it cannot be defended

Risk-adjusted revenue gets audited. When it does, the question is what was in the chart, who put it there and what supported it. "Our vendor's model flagged it" is not a defence, and the organisations that learned this lesson expensively will ask you about it in the first meeting.

Three: it costs somebody their evening

If the only path from your product into the chart is a human retyping it, you have not removed work. You have moved it onto the person least able to absorb more of it, and you are now competing against the status quo plus the cost of that person's goodwill.

This is the quiet reason pilots stall without ever being formally rejected. Usage decays, nobody says why, and the renewal conversation simply does not get scheduled.

What to do about it commercially

Two things, and neither one is a technical fix.

First, raise it yourself, early, before the buyer does. "Here is exactly how this lands in Epic, here is what the coder sees, and here is what an auditor would find" is one of the most credibility-generating things a healthcare AI company can say out loud in a first meeting. It signals that you have met this problem before, which almost no vendor does.

Second, if the writeback genuinely does not exist yet, say that too, and be specific about what the workflow looks like in the meantime and who absorbs it. Buyers can work with a gap they were told about. They cannot forgive one they discovered in month four.

Integration is not a technical detail to be handled after the sale. In healthcare it is often the deal.

Katie Jackson is the founder of Unbound Growth Advisory, which builds the commercial foundation healthcare companies skip. Twenty-seven years inside healthcare’s buying process, then three commercial organizations built or rebuilt from nothing. Start a conversation or read the FAQ.